Brinkmann Melanie M, Glenn Mark, Rainbow Lucille, Kieser Arnd, Henke-Gendo Cornelia, Schulz Thomas F
Institut für Virologie, Medizinische Hochschule Hannover, D-30625 Hannover, Germany.
J Virol. 2003 Sep;77(17):9346-58. doi: 10.1128/jvi.77.17.9346-9358.2003.
The K15 gene of Kaposi's sarcoma-associated herpesvirus (also known as human herpesvirus 8) consists of eight alternatively spliced exons and has been predicted to encode membrane proteins with a variable number of transmembrane regions and a common C-terminal cytoplasmic domain with putative binding sites for SH2 and SH3 domains, as well as for tumor necrosis factor receptor-associated factors. These features are reminiscent of the latent membrane proteins LMP-1 and LMP2A of Epstein-Barr virus and, more distantly, of the STP, Tip, and Tio proteins of the related gamma(2)-herpesviruses herpesvirus saimiri and herpesvirus ateles. These viral membrane proteins can activate a number of intracellular signaling pathways. We have therefore examined the abilities of different K15-encoded proteins to initiate intracellular signaling. We found that a 45-kDa K15 protein derived from all eight K15 exons and containing 12 predicted transmembrane domains in addition to the cytoplasmic domain activated the Ras/mitogen-activated protein kinase (MAPK) and NF-kappaB pathways, as well as (more weakly) the c-Jun N-terminal kinase/SAPK pathway. Activation of the MAPK and NF-kappaB pathways required phosphorylation of tyrosine residue 481 within a putative SH2-binding site (YEEVL). This motif was phosphorylated by the tyrosine kinases Src, Lck, Yes, Hck, and Fyn. The region containing the YEEVL motif interacted with tumor necrosis factor receptor-associated factor 2 (TRAF-2), and a dominant negative TRAF-2 mutant inhibited the K15-mediated activation of the Ras/MAPK pathway, suggesting the involvement of TRAF-2 in the initiation of these signaling routes. In contrast, several smaller K15 protein isoforms activated these pathways only weakly. All of the K15 isoforms tested were, however, localized in lipid rafts, suggesting that incorporation into lipid rafts is not sufficient to initiate signaling. Additional regions of K15, located presumably in exons 2 to 5, may therefore contribute to the activation of these pathways. These findings illustrate that the 45-kDa K15 protein engages pathways similar to LMP1, LMP2A, STP, Tip, and Tio but combines functional features that are separated between LMP1 and LMP2A or STP and Tip.
卡波西肉瘤相关疱疹病毒(也称为人类疱疹病毒8)的K15基因由8个可变剪接外显子组成,预计可编码具有不同数量跨膜区域的膜蛋白以及一个常见的C端胞质结构域,该结构域具有SH2和SH3结构域以及肿瘤坏死因子受体相关因子的假定结合位点。这些特征使人联想到爱泼斯坦-巴尔病毒的潜伏膜蛋白LMP-1和LMP2A,以及更远相关的γ(2)-疱疹病毒赛米利疱疹病毒和阿氏疱疹病毒的STP、Tip和Tio蛋白。这些病毒膜蛋白可激活多种细胞内信号通路。因此,我们研究了不同K15编码蛋白启动细胞内信号的能力。我们发现,一种由所有8个K15外显子产生、除胞质结构域外还含有12个预测跨膜结构域的45 kDa K15蛋白激活了Ras/丝裂原活化蛋白激酶(MAPK)和NF-κB通路,以及(较弱地)c-Jun N端激酶/SAPK通路。MAPK和NF-κB通路的激活需要假定的SH2结合位点(YEEVL)内酪氨酸残基481的磷酸化。该基序被酪氨酸激酶Src、Lck、Yes、Hck和Fyn磷酸化。包含YEEVL基序的区域与肿瘤坏死因子受体相关因子2(TRAF-2)相互作用,一种显性负性TRAF-2突变体抑制了K15介导的Ras/MAPK通路激活,表明TRAF-2参与了这些信号通路的启动。相比之下,几种较小的K15蛋白异构体仅微弱激活这些通路。然而,所有测试的K15异构体都定位于脂筏,这表明整合到脂筏中不足以启动信号。因此,K15的其他区域,可能位于外显子2至5中,可能有助于激活这些通路。这些发现表明,45 kDa K15蛋白参与了与LMP1、LMP2A、STP、Tip和Tio相似的通路,但结合了LMP1和LMP2A或STP和Tip之间分开的功能特征。